Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Weekly Report: what happened at PJP last week (0415-0419)?

Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management

Home Market Outlook Today's Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management. Neuberger Berman: U.S. Economic growth has remained resilient and leads the world. Global Industrial Activity Is Picking Up While Early Signs Of Moderating Growth in Europe. We believe extreme market consensus presents a moment for active management.

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Weekly Report: what happened at PJP last week (0408-0412)?

Weekly Report: what happened at PJP last week (0401-0405)?

Friday's ETF with Unusual Volume: PJP

Weekly Report: what happened at PJP last week (0325-0329)?

Cons Disc distribution & retail has the highest dispersion among S&P groups - MS

Consumer discretionary distribution & retail has the highest dispersion among S&P groups. Morgan Stanley analysts monitored the dispersion metrics of the S&p 500 and its sectors and subsectors. Dispersion measures the range of returns for a group, Morgan Stanley says. High dispersion present in auto and household, lower in utilities and energy.

Weekly Report: what happened at PJP last week (0318-0322)?

Taking Stock: Q2 2024 Equity Market Outlook

Invesco Dynamic Pharmaceuticals ETF declares quarterly distribution of $0.1695

Weekly Report: what happened at PJP last week (0311-0315)?

2024 Outlook: A New 'Super Boom'? Or Chop And Churn?

Weekly Report: what happened at PJP last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Weekly Report: what happened at PJP last week (0226-0301)?

Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?

PJP: Pharma Investing Is Difficult And This Fund Doesn't Make It Easier

Invesco Dynamic Pharmaceuticals ETF is a passively managed fund that tracks the Dynamic Pharmaceutical Intellidex Index. Investing in the pharmaceutical industry is challenging due to the need for specialized knowledge and the industry's underperformance. PJP is overvalued, has lower expected earnings growth, and higher fees compared to its competitors.